Cargando…

Precision Medicine of Hepatobiliary and Pancreatic Cancers: Focusing on Clinical Trial Outcomes

SIMPLE SUMMARY: Recently, tumor-agnostic precision medicine employing comprehensive genome profiling (CGP) and using next-generation sequencing (NGS) has been progressing. This review focuses on the recent progress in precision medicine for advanced unresectable hepatobiliary and pancreatic cancers....

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsumura, Takehiko, Doi, Keitaro, Marusawa, Hiroyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367472/ https://www.ncbi.nlm.nih.gov/pubmed/35954337 http://dx.doi.org/10.3390/cancers14153674

Ejemplares similares

Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers
por: Eso, Yuji, et al.
Publicado: (2019)

Hereditary Pancreatic and Hepatobiliary Cancers
por: Haddad, Ashraf, et al.
Publicado: (2011)

Textbook outcomes in hepatobiliary and pancreatic surgery
por: Tsilimigras, Diamantis I, et al.
Publicado: (2021)

Cancer vaccines and immunotherapeutic approaches in hepatobiliary and pancreatic cancers
por: Hochnadel, Inga, et al.
Publicado: (2017)

Hepatobiliary and pancreatic ascariasis
por: Khuroo, Mohammad S, et al.
Publicado: (2016)

MicroRNAs in Hepatobiliary and Pancreatic Cancers
por: Saito, Yoshimasa, et al.
Publicado: (2011)

Hepatobiliary and pancreatic surgery in the elderly: Current status
por: Papis, Davide, et al.
Publicado: (2020)

Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers
por: Marin, Jose J. G., et al.
Publicado: (2022)

Prospective comparison of diagnostic performance of magnifying endoscopy and biopsy for sessile serrated adenoma/polyp
por: Yamashina, Takeshi, et al.
Publicado: (2022)

Molecular Subtyping and Precision Medicine for Pancreatic Cancer
por: Froeling, Fieke E. M., et al.
Publicado: (2021)

Current status of treatment with immune checkpoint inhibitors for gastrointestinal, hepatobiliary, and pancreatic cancers
por: Eso, Yuji, et al.
Publicado: (2020)

Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice?
por: Boilève, Alice, et al.
Publicado: (2021)

The State of Immunotherapy in Hepatobiliary Cancers
por: Ilyas, Farhan Z., et al.
Publicado: (2021)

Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota
por: Perelló-Reus, Catalina M., et al.
Publicado: (2022)

Hepatobiliary tuberculosis
por: Chaudhary, Poras
Publicado: (2014)

From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers
por: Kyrochristos, Ioannis D., et al.
Publicado: (2017)

Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
por: Sereti, Evangelia, et al.
Publicado: (2023)

The Present and Future of Precision Medicine in Psychiatry: Focus on Clinical Psychopharmacology of Antidepressants
por: Serretti, Alessandro
Publicado: (2018)

Laparoscopic hepatobiliary and pancreatic surgery: my trials and current status in Korea
por: Yun, Sung Su
Publicado: (2021)

Hepatobiliary Schistosomiasis
por: Shaker, Yehia, et al.
Publicado: (2014)

RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
por: Chen, Shao-Long, et al.
Publicado: (2021)

Advances in Targeted Immunotherapy for Hepatobiliary Cancers
por: Ruff, Samantha M., et al.
Publicado: (2022)

Advances in the Early Detection of Hepatobiliary Cancers
por: Yıldırım, Hasan Çağrı, et al.
Publicado: (2023)

Hepatobiliary and Pancreatic Manifestations of Coronavirus Disease 2019
por: Singla, Vikas, et al.
Publicado: (2020)

Gastrointestinal, hepatobiliary, and pancreatic manifestations of COVID-19
por: Patel, Kishan P., et al.
Publicado: (2020)

Role of artificial intelligence in hepatobiliary and pancreatic surgery
por: Bari, Hassaan, et al.
Publicado: (2021)

Hepatobiliary and pancreatic hemorrhage: Technical tools and tricks
por: Ball, Chad G.
Publicado: (2021)

Hepatobiliary and Pancreatic: An unusual cause of biliary obstruction
por: Saraiva, RO, et al.
Publicado: (2022)

Clinical trial design in the era of precision medicine
por: Fountzilas, Elena, et al.
Publicado: (2022)

Current Strategies and Future Perspectives for Precision Medicine in Pancreatic Cancer
por: Regel, Ivonne, et al.
Publicado: (2020)

Organ-Chip Models: Opportunities for Precision Medicine in Pancreatic Cancer
por: Haque, Muhammad R., et al.
Publicado: (2021)

Reshaping preoperative treatment of pancreatic cancer in the era of precision medicine
por: Casolino, R., et al.
Publicado: (2021)

Three-dimensional imaging for hepatobiliary and pancreatic diseases: Emphasis on clinical utility
por: Kim, Soo Jin, et al.
Publicado: (2009)

Effects of cancer stigma on quality of life of patients with hepatobiliary and pancreatic cancer
por: Kim, Naru, et al.
Publicado: (2023)

Precision Medicine in Pancreatitis: The Future of Acute Pancreatitis Care
por: Garami, Andras, et al.
Publicado: (2023)

Hepatobiliary and pancreatic imaging in children—techniques and an overview of non-neoplastic disease entities
por: Nievelstein, Rutger A. J., et al.
Publicado: (2010)

Review of Current Applications of Immunohistochemistry in Pediatric Nonneoplastic Gastrointestinal, Hepatobiliary, and Pancreatic Lesions
por: de Nanassy, Joseph, et al.
Publicado: (2017)

Molecular genomic landscapes of hepatobiliary cancer
por: Shibata, Tatsuhiro, et al.
Publicado: (2018)

Current status and issues in genomic analysis using EUS-FNA/FNB specimens in hepatobiliary–pancreatic cancers
por: Ozono, Yoshinori, et al.
Publicado: (2023)

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine
por: Lomberk, Gwen, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ajcck3fm0o4c14h2bud4dedfa3